Company / Gross Margin
Johnson & Johnson Gross Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
67.9%
FY2025
5-year range
67.9% / 70.3%
FY2021-FY2025
Trend
-1.7%
vs FY2024
Sector context
#13 of 28
Health Care
What the data says
At 67.9%, Johnson & Johnson's gross margin ranks #13 of 28 in the Health Care sector. Gross Margin remained relatively stable over the past 10 years, with values between 65.6% and 70.3%.
Based on SEC 10-K filings.
67.9% in FY2025 with a 5-year CAGR of +2.3%.
Remained stable around 67.9% over the past 2 years.
Health Care sector context is included.
Gross Margin over time
Growth rates
- 3-Year Change
- -1.4pp
- 5-Year Change
- +2.3pp
- 10-Year Change
- -
Sector benchmark
#13 of 28 in Health CareTop 46% of 28This company 67.9% Sector average 60.3%
▼
+12.6% above sector average
Key checks
Key Insights
- In FY2025, gross margin decreased 1.7% year-over-year.
- Currently 7.6pp above the Health Care sector average.
- Peak gross margin was recorded in FY2021.
- Lowest gross margin in the period was in FY2020.
Company context
Key Data Points
- Strong profit margin: 27.3%
- Strong return on equity: 31.7%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 67.9% | -1.7% |
| FY2024 | 69.1% | +0.4% |
| FY2023 | 68.8% | -0.6% |
| FY2022 | 69.3% | -1.5% |
| FY2021 | 70.3% | +7.2% |
| FY2020 | 65.6% | -1.3% |
| FY2019 | 66.4% | -0.6% |
| FY2018 | 66.8% | +0.1% |
| FY2017 | 66.7% | -4.3% |
| FY2016 | 69.7% | +0.6% |
As of FY2025 · SEC 10-K · Updated Mar 11, 2026